» Articles » PMID: 26779263

Mesenchymal Stem Cells Derived from Dental Pulp: A Review

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2016 Jan 19
PMID 26779263
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

The mesenchymal stem cells of dental pulp (DPSCs) were isolated and characterized for the first time more than a decade ago as highly clonogenic cells that were able to generate densely calcified colonies. Now, DPSCs are considered to have potential as stem cell source for orthopedic and oral maxillofacial reconstruction, and it has been suggested that they may have applications beyond the scope of the stomatognathic system. To date, most studies have shown that, regardless of their origin in third molars, incisors, or exfoliated deciduous teeth, DPSCs can generate mineralized tissue, an extracellular matrix and structures type dentin, periodontal ligament, and dental pulp, as well as other structures. Different groups worldwide have designed and evaluated new efficient protocols for the isolation, expansion, and maintenance of clinically safe human DPSCs in sufficient numbers for various therapeutics protocols and have discussed the most appropriate route of administration, the possible contraindications to their clinical use, and the parameters to be considered for monitoring their clinical efficacy and proper biological source. At present, DPSC-based therapy is promising but because most of the available evidence was obtained using nonhuman xenotransplants, it is not a mature technology.

Citing Articles

Multiomics analyses reveal adipose-derived stem cells inhibit the inflammatory response of M1-like macrophages through secreting lactate.

Horie T, Hirata H, Sakamoto T, Kitajima H, Fuku A, Nakamura Y Stem Cell Res Ther. 2024; 15(1):485.

PMID: 39696485 PMC: 11657992. DOI: 10.1186/s13287-024-04072-w.


Anti-necroptotic effects of human Wharton's jelly-derived mesenchymal stem cells in skeletal muscle cell death model via secretion of GRO-α.

Park S, Kwon S, Kim S, Jeong J, Kim M, Choi S PLoS One. 2024; 19(12):e0313693.

PMID: 39621655 PMC: 11611217. DOI: 10.1371/journal.pone.0313693.


Role of the Stem Cells from Human Deciduous Teeth in Dentistry: A Review.

Pawar M, Rathi N, Kharat A, Bhonde R, Patole V J Pharm Bioallied Sci. 2024; 16(Suppl 3):S1974-S1976.

PMID: 39346474 PMC: 11426779. DOI: 10.4103/jpbs.jpbs_630_24.


Potential Mechanism and Perspectives of Mesenchymal Stem Cell Therapy for Ischemic Stroke: A Review.

Zhu P, Tan H, Gao H, Wang J, Liu Y, Yang D Glob Med Genet. 2024; 11(4):278-284.

PMID: 39224463 PMC: 11368559. DOI: 10.1055/s-0044-1790231.


Effects of EZH2 inhibitor, trichostatin A, and 5-azacytidine combinatorial treatment on osteogenic differentiation of dental pulp stem cells.

Hrubi E, Imre L, Hegedus C Heliyon. 2024; 10(12):e32553.

PMID: 39183840 PMC: 11341346. DOI: 10.1016/j.heliyon.2024.e32553.


References
1.
Pihlstrom B, Michalowicz B, Johnson N . Periodontal diseases. Lancet. 2005; 366(9499):1809-20. DOI: 10.1016/S0140-6736(05)67728-8. View

2.
Reinhardt J, Stuhler A, Blumel J . Safety of bovine sera for production of mesenchymal stem cells for therapeutic use. Hum Gene Ther. 2011; 22(6):775. DOI: 10.1089/hum.2011.2501. View

3.
Gronthos S, Brahim J, Li W, Fisher L, Cherman N, Boyde A . Stem cell properties of human dental pulp stem cells. J Dent Res. 2002; 81(8):531-5. DOI: 10.1177/154405910208100806. View

4.
Graziano A, dAquino R, Laino G, Proto A, Giuliano M, Pirozzi G . Human CD34+ stem cells produce bone nodules in vivo. Cell Prolif. 2008; 41(1):1-11. PMC: 6496867. DOI: 10.1111/j.1365-2184.2007.00497.x. View

5.
Gronthos S, Zannettino A, Hay S, Shi S, Graves S, Kortesidis A . Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci. 2003; 116(Pt 9):1827-35. DOI: 10.1242/jcs.00369. View